MétaCan
Menu
Back to cohort
Record W4410982365 · doi:10.1016/j.waojou.2025.101066

Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR)

2025· article· en· W4410982365 on OpenAlexafffund
Florence Schleich, Désirée Larenas‐Linnemann, Alan Altraja, Luis Pérez de Llano, Κonstantinos Κostikas, Mohsen Sadatsafavi, Arnaud Bourdin, Roy A. Pleasants, Mark Hew, Wenjia Chen, Libardo Jiménez-Maldonado, Simon Couillard, Charlotte Suppli Ulrik, Adeeb A. Bulkhi, Ming‐Ju Tsai, George Christoff, Nikolaos G. Papadopoulos, Paul Pfeffer, Dermot Ryan, Céline Bergeron, Mona Al‐Ahmad, Delbert R. Dorscheid, Eileen Wang, John Blakey, Belinda Cochrane, Matthew Peters, Todor A. Popov, Carlos A. Torres‐Duque, Susanne Hansen, Francesca Puggioni, Kirsty Fletton, Laila Salameh, Peter G. Middleton, Paulo Márcio Pitrez, Chin Kook Rhee, Eve Denton, Kenneth R. Chapman, Lauri Lehtimäki, Ruth Murray, Chau‐Chyun Sheu, David J. Jackson, Riyad Al‐Lehebi, Mariko Siyue Koh, Bassam Mahboub, Ledit Ardusso, Athena Gogali, Giorgio Walter Canonica, Piotr Kuna, Martín Sívori, Renaud Louis, Shelley Abercromby, Giuseppe Guida, Bernt Bøgvald Aarli, Aaron Beastall, Victoria Carter, Ghislaine Scélo, John Townend, Borja G. Cosío, Pujan H. Patel, Celine Goh, Zsuzsanna Csoma, John W. Upham, João Fonseca, Peter G. Gibson, Christine Jenkins, Guy Brusselle, Anne Chèvremont, Andréanne Côté, Iván Solarte, Celeste Porsbjerg, Asger Sverrild, Paula Kauppi, Stelios Loukides, Μichael Μakris, Andriana Ι. Papaioannou, Enrico Heffler, Jeffrey Shi Kai Chan, Hyonsoo Joo, Liam G. Heaney, Wei‐Han Cheng, Njira Lugogo, Michael E. Wechsler, Bellanid Rodríguez-Cáceres, Tatsuya Nagano, Zhixiao Wang, Hao‐Chien Wang, Jorge Máspero, Fernando Saldarini, Ana María Stok, Anahí Yáñez, Philip G. Bardin, Sinthia Bosnic‐Anticevich, Vidya Navaratnam, Mohit Bhutani, M. Diane Lougheed, Lyle Melenka, Petros Bakakos, Konstantinos Exarchos, Aggelos Ladias, Dóra Lúðvíksdóttir, Takashi Iwanaga, Elvia Angelica Contreras Contreras, Sverre Lehmann, José Alberto Ferreira, Rebecca Gall, Pin‐Kuei Fu, Diahn‐Warng Perng, Flavia Hoyte, Rohit Katial, Unnur Steina Björnsdóttir, Camille Taillé, Christian Taube, Breda Cushen, Lakmini Bulathsinhala, Leif Bjermer, David Price

Bibliographic record

VenueWorld Allergy Organization Journal · 2025
Typearticle
Languageen
FieldMedicine
TopicAsthma and respiratory diseases
Canadian institutionsVancouver General HospitalKingston General HospitalUniversity of AlbertaUniversité LavalVancouver Coastal Health Research InstituteEmissions Reduction AlbertaVancouver Coastal HealthUniversité de SherbrookeUniversity of TorontoQueen's UniversityVancouver Hospital and Health Sciences CentreUniversity of British Columbia
FundersFaculty of Medicine and Health, University of SydneyDaiichi Sankyo EuropeMedical Research CouncilCanadian Institutes of Health ResearchSanofi GenzymeDirectorate for Biological SciencesNovartis Pharmaceuticals UK LimitedNational Jewish HealthHumanitas Research HospitalLung Health FoundationGrifolsOrient EuropharmaKing Fahad Medical CityBritish Columbia Lung AssociationTeva Pharmaceutical IndustriesAlfaisal UniversityCentro de Investigação em Tecnologias e Serviços de SaúdeGenentechUniversity of AlbertaStiftung Universitätsmedizin EssenShirePontificia Universidad JaverianaUniversidad del RosarioVancouver Coastal Health Research InstituteKuwait Foundation for the Advancement of SciencesUniversidade do PortoAstraZeneca AustraliaNovo NordiskSwedish Orphan BiovitrumUniversitetet i BergenQueen's UniversityLunds UniversitetQueen's University BelfastShanghai Educational Development FoundationTaichung Veterans General HospitalAsthma AustraliaBispebjerg HospitalUniversity of New South WalesSingapore General HospitalSkånes universitetssjukhusErasmus Medisch CentrumThoracic Society of Australia and New ZealandModernaAllergy TherapeuticsAstraZenecaInsmedUniversity of AberdeenKing's College LondonMichael Smith Health Research BCCatholic University of KoreaCanadian Lung AssociationUniversity of TorontoMacquarie UniversityCollege of Medicine, Catholic University of KoreaShionogiHunter Medical Research InstituteUniversidad Nacional de RosarioAmerican Thoracic SocietyOptimum Patient CareHaukeland UniversitetssjukehusUniversiteit GentChiesi FarmaceuticiGlaxoSmithKlineCerecorPfizerUniversidad de Buenos AiresMonash UniversityUnited Therapeutics CorporationHorizon TherapeuticsNational Institute for Health and Care ResearchUniversity of QueenslandTaysWestern Sydney UniversityHáskóli ÍslandsLandspítali HáskólasjúkrahúsKindai UniversityNational and Kapodistrian University of AthensSeoul St. Mary's Hospital, Catholic University of KoreaKanazawa UniversityUCB PharmaCystic Fibrosis FoundationMylanInstituto de Seguriidad y Servicios Sociales de los Trabadores del EstadoCanadian Thoracic SocietyRegeneron PharmaceuticalsUniversitair Ziekenhuis GentGovernment of OntarioHumanitas UniversityUniwersytet ŁódzkiHelsingin YliopistoUniversité LavalSeqirusBristol-Myers SquibbEuropean Respiratory SocietySanofiCSL BehringGlenmark PharmaceuticalsDanoneGilead SciencesCelltrion HealthcareUniversità degli Studi di TorinoCovis PharmaUniversity of British ColumbiaEli Lilly and CompanyCelltrionIncyteCurtin University of TechnologyTaipei Veterans General HospitalAmgen
KeywordsMedicineAsthmaBiomarkerCorticosteroidDiseaseIntensive care medicinePediatricsInternal medicine

Abstract

fetched live from OpenAlex

Background: Asthma characterization using blood eosinophil count (BEC) (among other biomarkers and clinical indices) is recommended in severe asthma (SA), but the masking effect of oral corticosteroids (OCS), makes this challenging. Aim: Our aim was to explore the effect of OCS use (both intermittent [iOCS] and long-term [LTOCS]) prior to biologic initiation on SA phenotype and biomarker profile in real-life and to characterize the burden of SA among patients prescribed LTOCS by biomarker profile. Methods: This was a registry-based cohort study, including data from 23 countries collected between 2003 and 2023 and shared with the Internatonal Severe Asthma Registry (ISAR). Patients with SA were categorized into 3 cohorts, those with: (i) no prescription for OCS, (ii) prescription(s) for iOCS (ie, ≤90 days in previous 12-months, usually short courses for exacerbations), and (iii) prescriptions for LTOCS (ie, >90 days in previous 12-months). Biomarker distribution (ie, BEC, fractional exhaled nitric oxide [FeNO], and total Immunoglobulin E [IgE]) were quantified in the year prior to biologic initiation in patients with SA according to OCS prescription pattern. Phenotypes were characterized for those prescribed LTOCS according to BEC cut-off (<150 and ≥ 150 cells/μL). Results: Of 4305 patients included, 5.0% (n = 215), 54.1% (n = 2330) and 40.9% (n = 1760) were prescribed no OCS, iOCS, and LTOCS, respectively. The BEC distribution varied by prescription pattern and LTOCS dose (<5 mg to ≥20 mg/day); BEC was <150 cells/μL in 28.6% (n = 369/1288) of LTOCS patients, compared to 19.5% (n = 284/1460) of iOCS patients and 14.0% (n = 21/150) of those in the no OCS group. Median BEC was also significantly lower in the LTOCS versus the iOCS group (310 vs 400 cells/μL; p < 0.001). A similar pattern was noted for IgE, but not FeNO. Among LTOCS patients with BEC <150 cells/μL, 39.9% experienced ≥4 exacerbations, 75.1% had uncontrolled asthma symptoms and 55.9% had evidence of persistent airflow obstruction (compared with 40.9%, 76.2% and 59.5% of those with BEC ≥150 cells/μL, respectively). Conclusions: OCS, whether prescribed intermittently or long term, affect BEC distribution potentially leading to heightened risk of phenotype misclassification and influencing subsequent treatment decisions. FeNO appears to be less susceptible to OCS-induced suppression. Disease burden was high for those in the LTOCS group and was high independent of dose and BEC. Our findings highlight the importance of considering OCS use, even intermittent use, when characterizing SA, and suggests the need for earlier phenotyping and alternative treatment strategies for LTOCS patients with low BEC.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.243
Teacher spread0.231 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueWorld Allergy Organization JournalSame topicAsthma and respiratory diseasesFrench-language works237,207